Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Classifica tra le azioni #27528
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Prezzo delle azioni
$0.0416118
Capitalizzazione di mercato
$32.25M
Variazione (1 giorno)
-1.67%
Variazione (1 anno)
-59.58%
Paese
AU
Scambia Neurizon Therapeutics Limited (NUZ)

Categoria

EPS per Neurizon Therapeutics Limited (NUZ)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Neurizon Therapeutics Limited, l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Neurizon Therapeutics Limited da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$17.32 -
US
$-7.98 -
US
$27.74 -
NL
$2.98 -
AU
- -
CH